sulfinpyrazone has been researched along with Diabetic Retinopathy in 1 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drago, F | 1 |
| La Manna, C | 1 |
| Emmi, I | 1 |
| Marino, A | 1 |
1 other study available for sulfinpyrazone and Diabetic Retinopathy
| Article | Year |
|---|---|
Effects of sulfinpyrazone on retinal damage induced by experimental diabetes mellitus in rabbits.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Male; Rabbits; Retina; Sulfinpyrazon | 1998 |